Technology
HIMSS23
Anna Schoenbaum, VP of information services at Penn Medicine, discusses the significance of technology for addressing social determinants of health, as well as how regulations mandate the use and collection of SDOH data.
It provides sleep coaching and a sleep score among other new features.
In a blog post, the virtual care provider blasts the insurer for paying it less than other providers in California and refusing to process 'every single' out-of-network claim.
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.
Simon-Kucher's Jan Bordon and Kay Schultze discuss how to encourage uptake for digital health products.
Also, Startoon has obtained a US FDA clearance for its wearable recovery tracking device.
HIMSS23
Toby Eadelman, CTO at AvaSure, discusses how AvaSure's digital offerings can help hospitals optimize their on-site acute-care nurses' workflows amid staffing challenges.
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and life sciences, also announced funding.
The company also laid off workers in the U.K. and Israel as it shifts focus to the U.S. market.
The company reported $33.3 million in revenue for Q1 2023 and a net loss of $8.8 million.